Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab
Ronald M BukowskiCleveland Clinic Taussig Cancer Center, CCF Lerner College of Medicine of CWRU Cleveland, OH, USAAbstract: The biology and pathogenesis of clear cell carcinoma of the kidney has been extensively investgated, and the role of von Hipple-Landau gene inactivation and tumor associated an...
Main Author: | Ronald M Bukowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/metastatic-clear-cell-carcinoma-of-the-kidney-therapeutic-role-of-beva-a4132 |
Similar Items
-
Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01) -
Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01) -
Solitary metastatic clear cell carcinoma to the spleen
by: Mohamed A. Zayed, et al.
Published: (2011-10-01) -
Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
by: Tong Meng, et al.
Published: (2019-10-01) -
Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma
by: Alejandro Mendoza-Alvarez, et al.
Published: (2019-05-01)